Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development

REHOVOT, Israel, Dec. 30, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, is pleased to announce the appointment of...

Read More